ARTICLE | Clinical News
Atragen tretinoin: Phase I/II
May 30, 2000 7:00 AM UTC
In ARNX's Phase I/II dose escalation trial of Atragen in combination with interferon alpha, 2 of 3 patients had partial remissions. The trial was started using doses of 90 mg/m2 Atragen every other da...